(Q34660922)

3 August 2017

1 reference

title

Fighting restenosis after coronary angioplasty: contemporary and future treatment options (English)

1 reference

3 August 2017

1 reference

Marc Horlitz

1

1 reference

3 August 2017

Ulrich Sigwart

series ordinal

2

1 reference

3 August 2017

Josef Niebauer

series ordinal

3

1 reference

3 August 2017

1 June 2002

1 reference

International Journal of Cardiology

3 August 2017

1 reference

3 August 2017

83

1 reference

3 August 2017

3

1 reference

3 August 2017

199-205

1 reference

Percutaneous transluminal coronary angioplasty

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Restenosis after coronary angioplasty: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a "magic bullet".

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Prevention of restenosis by lovastatin after successful coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

The evolving role of statins in the management of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Current and future treatment of hyperlipidemia: the role of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Effect of statin therapy on restenosis after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Gene transfer of nitric oxide synthase: effects on endothelial biology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900033-5

7 January 2021

10.1016/S0167-5273(02)00033-5

Identifiers

DOI

1 reference

release_g2aituf7zzf67i5mgv4gtaaxly

3 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g2aituf7zzf67i5mgv4gtaaxly

24 November 2022

mapped directly with Wikidata item

1 reference